Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/ml Polihexanide

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 30, 2025

Conditions
Acanthamoeba Keratitis
Trial Locations (10)

6777

AZIENDA ULSS 3 Serenissima-UOC Oculistica, Venice

20132

IRCCS Ospedale San Raffaele, Milan

20157

ASST Fatebenefratelli Sacco, Milan

25121

ASST Spedali Civili, Brescia

27100

Policlinico S. Matteo, Pavia

37126

Azienda Ospedaliera Universitaria Verona, Verona

50134

SOD Oculistica Azienda Ospedaliero Universitaria Careggi, Florence

98124

Policlinico G.Martino, Messina

00133

Policlinico TorVergata, Rome

Policlinico Universitario Campus Biomedico, Rome

All Listed Sponsors
lead

SIFI SpA

INDUSTRY

NCT06641882 - Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/ml Polihexanide | Biotech Hunter | Biotech Hunter